Development↦Management↦Biobanking↦Management
What is it? Why is it important?
A Biobank (BB) is an organized entity with a governance in place, responsible for the management of Biological Material (BM).
In studies, biobanks are responsible for the workflow management of BM (e.g. collection, transport, processing, storage, analysis, and if applicable destruction)
Biobank management include aspects such as:
- Donor consent: in studies, research projects, further-use
- Data confidentiality: coding / anonymization of BM, including the establishment of a participant identification-log
- Definition of BM: liquid, tissue, organ, healthy or diseased
- Storage method: fresh-frozen, formalin-fixed, paraffin-embedded
- Storage equipment: restricted access, temperature controlled freezers
- Risk assessment: emergency plan by equipment failure
- Quality control: collection, transport, processing, storage, analysis
Upon collection, biological samples should be coded as quickly as possible. This ensures that participant identity remains concealed (data confidentiality), and data protection issues are respected at all times.
What do I need to do?
As a SP-INV and Site-INV, make yourself familiar with the field of biobanking, such as:
- Infrastructure and technical equipment (e.g. access-controlled storage rooms, freezers, 24-hour temperature monitoring)
- Resources for managing a BB (e.g. BB staff, infrastructure, finances)
- Software to document and track BM (e.g. BIMS)
- Processes to ensure the ongoing quality of BM during the entire sample workflow
- Training of personnel responsible for BB activities
- Restricted access and adherence to data protection laws
- BB governance and SOPs that define BB management and responsibilities
To ensure the reproducibility and comparability of analytical results, the handling of BM must remain consistent. Thus, define standardised procedures for:
- Collection and transport (e.g. collection tubes, approved stabilisers, transport on dry ice)
- Sample processing and storage
- Analysis of BM
Define maximum acceptable time-lapse between different handling steps. Delays may jeopardize the quality of BM. Ensure all implemented handling steps are well documented.
Where can I get help?
Your local CTU↧ can support you with experienced staff regarding this topic
Basel, Departement Klinische Forschung, CTU, dkf.unibas.ch
Lugano, Clinical Trials Unit, CTU-EOC, www.ctueoc.ch
Bern, Clinical Trials Unit, CTU, www.ctu.unibe.ch
Geneva, Clinical Research Center, CRC, crc.hug.ch
Lausanne, Clinical Research Center, CRC, www.chuv.ch
St. Gallen, Clinical Trials Unit, CTU, www.kssg.ch
Zürich, Clinical Trials Center, CTC, www.usz.ch
The Swiss Biobanking Platform (SBP) can provide you with support on this topic.
SBP Documents
- Ethical, legal and professional compliance list for human research biobanks applicable in Switzerland
External Links
Swissethics - see in particular
- Topics / Biobanks and data registries
SECB - see in particular Topics / Definitions
- Transport of biological material
References
Declaration of Taipei – see in particular
- Health database and biobank governance
ISO 20387:2018 General requirement for biobanking (access liable to costs) – see in particular
- 3.6 Definition of biobanking
Swiss Law
ClinO – see in particular article
- Art. 18 Storage of health-related personal data and biological material
HRO – see in particular article
- Art. 5 – Storage of health-related personal data and biological material